Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
PUMP ProPetro Holding Corp
CHK Chesapeake Energy Corp
SALM Salem Media Group Inc
UGAZ VelocityShares 3x Long Natural Gas ETN Linked to the S&P GSCI? Natural Gas Index ER
UBSI United Bankshares Inc
LTM LATAM Airlines Group SA
TRGP Targa Resources Corp
PFE Pfizer Inc
SOIEF Stolt-Nielsen Ltd
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
$75.16
Day's Change
-2.67 (-3.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
76.90
Day's Low
74.38
Volume
(Above Average)
Volume:
14,677,206

10-day average volume:
13,051,836
14,677,206
  • Prev Close
    77.83
  • Today's Open
    75.47
  • Day's Range
    74.38-76.90
  • Avg Vol (10-day)
    13.1M
  • Last (time)
    4:00p ET 06/01/20
  • Last (size)
    55
  • 52-Wk Range
    60.89 - 85.97
    LowHigh
  • (10/03/19 - 03/19/20)
    12.57%
  • 36.4%
  • Market Cap
    94.3B
  • Shares Outstanding
    1.3B
  • 3.89
  • 20.01x
  • $2.72/3.49%
  • Ex-dividend Date
    06/11/20
  • Dividend Pay Date
    06/29/20
  • 0.7
  • 80.84
  • (% of float 05/15/20)
    2.07

Latest News

June 01, 2020
4:05 pm ET
BusinessWire
3:02 pm ET
MarketWatch
10:46 am ET
Zacks
8:49 am ET
MarketWatch
8:45 am ET
PR Newswire
8:34 am ET
MarketWatch
8:30 am ET
BusinessWire
May 29, 2020
8:00 am ET
BusinessWire
8:00 am ET
BusinessWire
May 28, 2020
3:16 pm ET
Globe Newswire
10:26 am ET
Zacks
7:34 am ET
MarketWatch
May 27, 2020
7:33 am ET
MarketWatch
7:11 am ET
BusinessWire
May 26, 2020
7:26 am ET
MarketWatch
May 22, 2020
7:15 pm ET
MarketWatch
2:22 pm ET
PR Newswire
10:30 am ET
Zacks
May 20, 2020
4:03 pm ET
BusinessWire
May 19, 2020
8:30 am ET
PR Newswire
May 16, 2020
12:02 pm ET
MarketWatch
May 14, 2020
2:37 pm ET
MarketWatch
May 13, 2020
5:00 pm ET
BusinessWire
May 12, 2020
4:16 pm ET
PR Newswire
2:55 pm ET
MarketWatch
8:50 am ET
PR Newswire
May 11, 2020
3:42 pm ET
MarketWatch
3:40 pm ET
MarketWatch
4:51 am ET
BusinessWire
May 09, 2020
2:19 pm ET
MarketWatch
11:42 am ET
MarketWatch
May 08, 2020
2:46 pm ET
MarketWatch
May 07, 2020
4:01 pm ET
BusinessWire
11:45 am ET
BusinessWire
May 06, 2020
10:30 am ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.